Discover
ACRS
Aclaris Therapeutics, Inc.
5.50
1 x 5.23
1 x 5.35
bid
ask
+
0.10
1.85%
1 @ 07:30 PM
5.41 -0.09 (1.64%)
| Ytd | 82.72% | |
| 1y | 182.05% |
5.36
day range
5.54
1.81
52 week range
6.53
| Open | 5.41 | Prev Close | 5.40 | Low | 5.36 | High | 5.54 | Mkt Cap | 809.59M |
| Vol | 4.69M | Avg Vol | 2.17M | EPS | -0.58 | P/E | N/A | Forward P/E | -5.00 |
| Beta | 0.12 | Short Ratio | 0.47 | Inst. Own | 90.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 5.79 | 200-d Avg | 4.33 | 1yr Est | 10.00 |
| Income Statement | |||
| Total Revenue | 1.63M | ||
| Revenues (USD) | 1.63M | ||
| Cost of Revenue | 1.45M | ||
| Gross Profit | 176.00K | ||
| Operating Expenses | 24.11M | ||
| Research and Development Expense | 18.07M | ||
| Selling, General and Administrative Expense | 6.05M | ||
| Operating Income | -23.94M | ||
| Net Income | -21.50M | ||
| Net Income Common Stock | -21.50M | ||
| Net Income Common Stock (USD) | -21.50M | ||
| Consolidated Income | -21.50M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -21.50M | ||
| Earning Before Interest & Taxes (USD) | -21.50M | ||
| Weighted Average Shares | 142.74M | ||
| Weighted Average Shares Diluted | 142.74M | ||
| Balance Sheet | |||
| Cash and Equivalents | 19.17M | ||
| Cash and Equivalents (USD) | 19.17M | ||
| Investments | 151.45M | ||
| Investments Current | 72.39M | ||
| Investments Non-Current | 79.07M | ||
| Trade and Non-Trade Receivables | 6.21M | ||
| Current Assets | 97.77M | ||
| Property, Plant & Equipment Net | 664.00K | ||
| Total Assets | 179.69M | ||
| Current Liabilities | 28.24M | ||
| Total Liabilities | 55.11M | ||
| Accumulated Retained Earnings (Deficit) | -1.01B | ||
| Accumulated Other Comprehensive Income | -304.00K | ||
| Shareholders Equity | 124.58M | ||
| Shareholders Equity (USD) | 124.58M | ||
| Assets Non-Current | 81.93M | ||
| Deferred Revenue | 18.29M | ||
| Liabilities Non-Current | 26.87M | ||
| Trade and Non-Trade Payables | 15.52M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 107.00K | ||
| Net Cash Flow from Financing | 91.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -9.49M | ||
| Capital Expenditure | -58.00K | ||
| Issuance (Purchase) of Equity Shares | 114.00K | ||
| Net Cash Flow from Investing | 10.26M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 10.32M | ||
| Net Cash Flow from Operations | -19.85M | ||
| Share Based Compensation | 2.67M | ||